Study tracks Texas youths being treated for depression

Nearly half of Texas youths being treated for depression or suicidal thoughts reported at least one suicide attempt, and 90% had experienced suicidal ideation, according to a study led by UT Southwestern Medical Center researchers. The findings, published in the journal Suicide and Life-Threatening Behavior, represent the data from a registry established in 2020 by the Texas Youth Depression and Suicide Research Network (TX-YDSRN).

Is psilocybin a promising therapy for treatment-resistant depression?

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions. However, many challenges remain in defining their clinical benefits and overcoming the complex regulatory obstacles to their use. The September issue of Journal of Psychiatric Practice presents a research review and update on therapeutic use of psychedelics—focusing on the use of psilocybin for treatment of depression.

ZAMMSA prepares for rainy season related diseases

By Nation Reporter

THE Zambia Medicines and Medical Supplies Agency (ZAMMSA) has stocked up adequate medical supplies in preparedness for the rainy season.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Elucidating the mechanism of aripiprazole action in treating circadian rhythm sleep disorders

While aripiprazole has long been a standard treatment for psychiatric disorders, such as schizophrenia and bipolar disorder, recent studies indicate that it is effective in treating circadian rhythm sleep disorders, including delayed sleep-phase syndrome. This condition causes patients to sleep and wake extremely late at times. However, the precise mechanism through which aripiprazole addresses these sleep disorder symptoms remains elusive.